Vicore Pharma Holding AB ADR (VCRE)

NASD · Healthcare · Biotechnology · Sweden

Vicore Pharma Holding AB ADR is a micro cap company (market value under $300 million) in the Biotechnology industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the Vicore Pharma Holding AB ADR stock.

Our verdict on VCRE

Not valued: We cannot value this company yet.

We do not publish a value for this company: it has no growth history of its own to project.

Peers in Biotechnology

All 600 Biotechnology stocks

Cheaper than VCRE in Biotechnology

129 more in this industry show a wider margin of safety.

Is VCRE undervalued or overvalued?

We do not publish a verdict on VCRE yet. A discounted cash flow projects five years of revenue, so it needs this company’s own growth history. We do not have it. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.

What is the intrinsic value of VCRE?

We do not publish one (as of the 2026-11-17 close). A discounted cash flow projects five years of revenue, so it needs this company’s own growth history. We do not have it. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.